Behçet's disease associated with myelodysplastic syndrome with elevated levels of inflammatory cytokines

Modern Rheumatology

Volumn 13, Issue 4, 2003, Pages 350-355

  Hasegawa, Hitoshi ^a   Iwamasa, Kikue ^a   Hatta, Nobuaki ^a   Fujita, Shigeru ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Beh et's disease; Cytokine; Fever; Myelodysplastic syndrome (MDS); Trisomy 8

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; COLCHICINE; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ADULT; ALOPECIA; ANAMNESIS; ARTICLE; BACTERIAL INFECTION; BEHCET DISEASE; BONE MARROW BIOPSY; BONE MARROW CELL; CASE REPORT; CELL FUNCTION; CELLULAR IMMUNITY; CHROMOSOME ANALYSIS; DIARRHEA; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHEMA NODOSUM; FEMALE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; GENITAL ULCER; HUMAN; HUMAN CELL; JAPAN; MOUTH ULCER; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; REFRACTORY ANEMIA; T LYMPHOCYTE; TRISOMY 8;

EID: 1142275257     PISSN: 14397595     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10165-003-0245-6     Document Type: Article

References (33)

1. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
2. Efthimiou J, Addison IE, Johnson BV. In vivo leucocyte migration in Behçet's syndrome. Ann Rheum Dis 1989;48:206-10.
3. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Auto-oxidative damage in Behçet's disease - endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982;49:247-55.
4. Yoshida Y, Stephenson J, Mufti GJ. Myelodysplastic syndromes: from morphology to molecular biology. Part I. Classification, natural history and cell biology of myelodysplasia. Int J Hematol 1993;57:87-97.
5. Saif MW, Hopkins JL, Gore SD. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Lymphoma 2002;43:2083-92.
6. Enright H, Miller W. Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 1997;24:483-9.
7. Billstrom R, Johansson H, Johansson B, Mitelman F. Immune-mediated complications in patients with myelodysplastic syndromes - clinical and cytogenetic features. Eur J Haematol 1995; 55:42-8.
8. Sakane T. New perspective on Behcet's disease. Int Rev Immunol 1997;14:89-96.
9. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte-derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20: 1544-9.
10. Takahama H, Itoh R, Inoue-Komatsu C, Furusawa S, Takahashi H, Mizoguchi M. Granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF) in Behçet's disease. J Dermatol 1994;21:546-52.
11. Ohno S, Kato F, Matsuda H, Fujii N, Minagawa T. Detection of gamma interferon in the sera of patients with Behçet's disease. Infect Immun 1982;36:202-8.
12. Fujii N, Minagawa T, Nakane A, Kato F, Ohno S. Spontaneous production of gamma-interferon in cultures of T lymphocytes obtained from patients with Behçet's disease. J Immunol 1983;130: 1683-6.
13. Hamzaoui K, Ayed K. Soluble interleukin-2 receptors in patients with Behçet's disease. J Rheumatol 1989;16:852-3.
14. al-Dalaan A, al-Sedairy S, al-Balaa S, al-Janadi M, Elramahi K, Bahabri S, et al. Enhanced interleukin 8 secretion in circulation of patients with Behçet's disease. J Rheumatol 1995;22:904-7.
15. Wang LM, Kitteringham N, Mineshita S, Wang JZ, Nomura Y, Koike Y, et al. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease. Arch Dermatol Res 1997;289:444-7.
16. Nawata R, Shinohara K, Takahashi T, Yamada T, Katsuki K. Refractory anemia with trisomy-8 complicated by Behçet's disease with elevated levels of inflammatory cytokines (in Japanese). Rinsho Ketsueki 1999;40:1100-4.
17. Nehashi Y, Torii Y, Yaguchi M, Itoh Y, Ohyashiki K, Toyama K. Incomplete form of Behçet's disease in a case of monopathic myelodysplastic syndrome presenting as a thrombocytopenia (in Japanese). Rinsho Ketsueki 1988;29:1097-102.
18. Nakayama S, Ishikawa T, Yabe H, Nagai K. Refractory anemia complicated by Behçet's disease - report of three cases (in Japanese). Rinsho Ketsueki 1989;30:530-4.
19. Takishita N, Horiuchi T, Hato T, Fujita S, Kobayashi Y. Myelodysplastic syndrome complicated with Behçet's disease (in Japanese). Ehime Igaku 1991;11:39-43.
20. Chyuma Y, Utsunomiya A, Saito T, Hanada S, Nishimata H, Arima T. Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome (in Japanese). Rinsho Ketsueki 1992;33: 333-7.
21. Yoshizawa Y, Hirai A, Izaki S, Kitamura K. Behçet's disease associated with myelodysplastic disorder (in Japanese). Hifu Rinsho 1992;34:1585-9.
22. Molina M, Aguayo JL, Ortega G, de Paco M, Cuesta F, Agudo MD. Non-specific digestive ulcers and Behçet's disease. An Med Interne 1992;9:237-8.
23. Yano K, Eguchi K, Migita K, Takashima H, Tamura M, Izumino K, et al. Behçet's disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature. Clin Rheumatol 1996;15:91-3.
24. Ohno E, Ohtsuka E, Watanabe K, Kohno T, Takeoka K, Saburi Y, et al. Behçet's disease associated with myelodysplastic syndromes. A case report and a review of the literature. Cancer 1997;79:262-8.
25. Della Rossa A, Tavoni A, Tognetti A, Testi C, Bombardieri S. Behçet's disease with gastrointestinal involvement associated with myelodysplasia in a patient with congenital panhypopituitarism. Clin Rheumatol 1998;17:515-7.
26. Bangerter M, Griesshammer M, v Tirpitz C, Krauter J, Heil G, Hafner M, et al. Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet's disease. Scand J Rheumatol 1999;28:117-9.
27. Oh EJ, Yoon JS, Park YJ, Cho CS, Kim BK. Behçet's disease associated with myelodysplastic syndrome: a case report. J Korean Med Sci 1999;14:685-7.
28. Tanaka E, Nishinarita M, Uesato M, Kamatani N. A case of intestinal Behçet's disease with abnormal ossification complicated by myelodysplastic syndrome. Symptoms revealed after the perforation of an ileum ulcer (in Japanese). Ryumachi 2000;40:711-8.
29. Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis - Behçet's syndrome. Leuk Lymphoma 2001;42:115-21.
30. Karuvannur S, Lipstein E, Brennessel D, Rosner F. A typical Behçet's syndrome in a patient with myelodysplastic syndrome. Mt Sinai J Med 2001;68:403-5.
31. Ohno S. Behçet's disease in the world. In: Lehner T, Barnes CG, editors. Recent advances in Behçet's disease. New York: Royal Society of Medicine Service; 1986. p. 181-6.
32. Sole F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, et al. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 1992;64:12-20.
33. Haase D, Fonatsch C, Freund M, Wormann B, Bodenstein H, Bartels H, et al. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 1995;70:171-87.